 Connection
Jordana Hoppe to Humans
This is a "connection" page, showing publications Jordana Hoppe has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.390 |
|
|
|
-
Hoppe JE, Paisley A, Vigers T, Moffett K, Indihar V, Dasenbrook E, Mortensen JE, Muhlebach MS, Siracusa C. Reliability of Clinic-Obtained vs Self-Obtained Respiratory Samples From the Self-Sample Accuracy and Benefit Implementation Trial (S2wAB-IT). Chest. 2026 Jun; 169(6):1488-1495.
Score: 0.023
-
Hoppe JE, Vigers T, Trujillo A, Hanley E, Sagel SD, Zemanick ET. Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis. Pediatr Pulmonol. 2025 Sep; 60(9):e71289.
Score: 0.023
-
Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G. Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial. Lancet Respir Med. 2025 Mar; 13(3):244-255.
Score: 0.022
-
Metcalf A, Martiniano SL, Sagel SD, Zaretsky MV, Zemanick ET, Hoppe JE. Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis. J Cyst Fibros. 2025 May; 24(3):466-468.
Score: 0.022
-
Good A, Shannon J, Brinton JT, Hoppe JE. Implementation and outcomes of a quality improvement project to systematically assess the gross motor skills in school-aged children with cystic fibrosis. Pediatr Pulmonol. 2024 Oct; 59(10):2597-2605.
Score: 0.021
-
Hoppe JE, Sjoberg J, Hong G, Poch K, Zemanick ET, Thee S, Edmondson C, Patel D, Sathe M, Borowitz D, Putman MS, Lechtzin N, Riekert KA, Basile M, Goss CH, Jarosz ME, Rosenfeld M. Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force. J Cyst Fibros. 2024 07; 23(4):725-733.
Score: 0.020
-
Jordan KD, Zemanick ET, Taylor-Cousar JL, Hoppe JE. Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy. Expert Rev Respir Med. 2023 02; 17(2):97-108.
Score: 0.019
-
Hoppe JE, Zemanick ET, Martiniano SL. Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing. Am J Respir Crit Care Med. 2022 12 01; 206(11):1308-1310.
Score: 0.019
-
Hoppe JE, Wagner BD, Kirk Harris J, Rowe SM, Heltshe SL, DeBoer EM, Sagel SD. Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D. J Cyst Fibros. 2022 11; 21(6):950-958.
Score: 0.018
-
Hoppe JE, Chilvers M, Ratjen F, McNamara JJ, Owen CA, Tian S, Zahigian R, Cornell AG, McColley SA. Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study. Lancet Respir Med. 2021 09; 9(9):977-988.
Score: 0.017
-
Hoppe JE, Hinds DM, Colborg A, Wagner BD, Morgan WJ, Rosenfeld M, Zemanick ET, Sanders DB. Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers. Pediatr Pulmonol. 2020 12; 55(12):3400-3406.
Score: 0.016
-
Hoppe JE, Guimbellot J, Martiniano SL, Toprak D, Davis C, Daines CL, Muhlebach MS, Esther CR, Dellon EP. Highlights from the 2019 North American Cystic Fibrosis Conference. Pediatr Pulmonol. 2020 09; 55(9):2225-2232.
Score: 0.016
-
Hoppe JE, Sagel SD. Shifting Landscape of Airway Infection in Early Cystic Fibrosis. Am J Respir Crit Care Med. 2019 Sep 01; 200(5):528-529.
Score: 0.015
-
Hoppe JE, Wagner BD, Accurso FJ, Zemanick ET, Sagel SD. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros. 2018 11; 17(6):760-768.
Score: 0.014
-
Muller PA, Mueller JL, Mellenthin M, Murthy R, Capps M, Wagner BD, Alsaker M, Deterding R, Sagel SD, Hoppe J. Evaluation of surrogate measures of pulmonary function derived from electrical impedance tomography data in children with cystic fibrosis. Physiol Meas. 2018 04 26; 39(4):045008.
Score: 0.014
-
Hoppe JE, Wagner BD, Sagel SD, Accurso FJ, Zemanick ET. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis. BMC Pulm Med. 2017 Dec 11; 17(1):188.
Score: 0.013
-
Hoppe JE, Zemanick ET. Lessons from the lower airway microbiome in early CF. Thorax. 2017 12; 72(12):1063-1064.
Score: 0.013
-
Hoppe JE, Towler E, Wagner BD, Accurso FJ, Sagel SD, Zemanick ET. Sputum induction improves detection of pathogens in children with cystic fibrosis. Pediatr Pulmonol. 2015 Jul; 50(7):638-46.
Score: 0.011
-
Muther EF, Gibson SL, Ford C, Duncan C, Riekert KA, Lyons E, Hoppe JE, Prickett M, Isenburg MV, Everhart RS. People with cystic fibrosis' experience of symptom burden while taking elexacaftor/tezacaftor/ivacaftor. Respir Med. 2026 Aug; 259:108908.
Score: 0.006
-
Metcalf A, Hoppe JE, Martiniano SL, Zaretsky MV, Zemanick ET, Sagel SD. In Utero CFTR Modulator Therapy in Fetuses With Cystic Fibrosis. Neoreviews. 2026 Mar 01; 27(3):e157-e169.
Score: 0.006
-
Melzer LD, Vigers T, Hanley ET, Messinger A, Hoppe JE, Sagel SD, Zemanick ET. Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children. Pediatr Pulmonol. 2025 Nov; 60(11):e71351.
Score: 0.006
-
Mayer-Hamblett N, Gifford AH, Kloster M, Russell R, Braun AT, Gibson RL, Hoppe JE, Jain R, Linnemann RW, Liou TG, Lysinger J, Milla C, Riekert KA, Sawicki GS, Young J, Nichols D. Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis. Ann Am Thorac Soc. 2024 11; 21(11):1507-1515.
Score: 0.005
-
Sanders DB, Bartz TM, Zemanick ET, Hoppe JE, Hinckley Stukovsky KD, Cogen JD, Bendy L, McNamara S, Enright E, Kime NA, Kronmal RA, Edwards TC, Morgan WJ, Rosenfeld M. A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment Strategies. Ann Am Thorac Soc. 2023 12; 20(12):1769-1776.
Score: 0.005
-
Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, Niu T, Weinstock T, Ratjen F, Rosenfeld M. Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele. Am J Respir Crit Care Med. 2023 07 01; 208(1):59-67.
Score: 0.005
-
Sagel SD, Kupfer O, Wagner BD, Davis SD, Dell SD, Ferkol TW, Hoppe JE, Rosenfeld M, Sullivan KM, Tiddens HAWM, Knowles MR, Leigh MW. Airway Inflammation in Children with Primary Ciliary Dyskinesia. Ann Am Thorac Soc. 2023 01; 20(1):67-74.
Score: 0.005
-
Lenhart-Pendergrass PM, Anthony M, Sariyska S, Andrews A, Scavezze H, Towler E, Martiniano SL, Hoppe JE, Zemanick ET. Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis. Pediatr Pulmonol. 2021 07; 56(7):2043-2047.
Score: 0.004
-
Hoppe JE, Wahrenberger C. Compliance of pediatric patients with treatment involving antibiotic suspensions: a pilot study. Clin Ther. 1999 Jul; 21(7):1193-201.
Score: 0.004
-
Hoppe JE, Schlegel M. [Detection of antibacterial activity in the urine of children: a comparison of three tests]. Klin Padiatr. 1999 Mar-Apr; 211(2):79-82.
Score: 0.004
-
Hoppe JE, von Einem C, Stern M. Evaluation of three methods for culturing alginate throat swabs from cystic fibrosis patients. Zentralbl Bakteriol. 1998 Dec; 288(4):457-61.
Score: 0.004
-
Hoppe JE, Holzwarth I, Stern M. Postal transport of sputa from cystic fibrosis patients does not decrease the microbiological yield. Zentralbl Bakteriol. 1997 Nov; 286(4):468-71.
Score: 0.003
-
Hoppe JE, Klausner M, Klingebiel T, Niethammer D. Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients. Mycoses. 1997 Jan-Feb; 40(1-2):47-54.
Score: 0.003
-
Hoppe JE, Holzwarth J, Stern M. Comparison of four methods for pretreatment of cystic fibrosis sputa. Eur J Clin Microbiol Infect Dis. 1996 Nov; 15(11):895-6.
Score: 0.003
-
Hoppe JE, Theurer-Mainka U, Stern M. Comparison of three methods for culturing throat swabs from cystic fibrosis patients. J Clin Microbiol. 1995 Jul; 33(7):1896-8.
Score: 0.003
-
Hoppe JE, Friess D, Niethammer D. Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes. Mycoses. 1995 Jan-Feb; 38(1-2):41-9.
Score: 0.003
-
Hoppe JE, Klingebiel T, Niethammer D. Orointestinal yeast colonization of paediatric bone marrow transplant recipients: surveillance by quantitative culture and serology. Mycoses. 1995 Jan-Feb; 38(1-2):51-7.
Score: 0.003
-
Martiniano SL, Hoppe JE, Sagel SD, Zemanick ET. Advances in the diagnosis and treatment of cystic fibrosis. Adv Pediatr. 2014 Aug; 61(1):225-43.
Score: 0.003
-
Hoppe JE, Köster S, Bootz F, Niethammer D. Acute mastoiditis--relevant once again. Infection. 1994 May-Jun; 22(3):178-82.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|